Please login to the form below

The changing face of pharma in the precision era

Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.

The changing face of pharma in the precision era

NATASHA COWAN|6TH SEPTEMBER 2019

Nancy Brandt is not your typical medical information specialist. While medical affairs teams are usually focused on developing scientific communications about a product or service for healthcare professionals, she has been tasked with preparing a top 20 biopharma company for the future of precision medicine.

For pharma, it’s clear the future lies in making the right partnerships. Precision medicine equates understanding the patient’s molecular makeup and using this information and other clinical data to find targeted treatments. However, right now the policies and regulations are still being written. New stakeholders are entering the fray and bringing with them novel technologies that can improve patient outcomes.

We are on the brink of a new way of practising medicine and pharmaceutical companies have the opportunity to shape this future, but this hinges on collaborating with the right people and listening to what the complex network of stakeholders are asking of them.

This means moving away from a product-specific way of thinking to develop a deep insight into how society is changing as precision medicines emerge. As a result, Nancy is immersed in understanding the patient journey and developing agile ways of working to ensure the organisation stays one step ahead of novel developments. Armed with this information, she can then develop partnerships that will fuel innovative communications for the 21st-century patient and the complex stakeholder network, from doctors to policymakers.

Here, she reveals how she is embracing this new way of working and the lessons she has learned along the way.

DOWNLOAD THE ARTICLE HERE

6th September 2019

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Digital therapeutics and their impact on society
Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?
Blue Latitude Health
Life with multiple myeloma - why I'm a lucky man living the dream
Multiple myeloma patient Bob Munro explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from London to the Arc de Triomphe.
Blue Latitude Health
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can position themselves as leaders at the forefront of these exciting innovations.
Blue Latitude Health
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why.
Blue Latitude Health
Launch Excellence 2020
In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch strategy for improving relationships between the customer and the brand.
Blue Latitude Health
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.
Blue Latitude Health